![]() |
ASCO Issues Updated Guideline On The Role Of Bone-Modifying Agents In The Prevention
The American Society of Clinical Oncology (ASCO) issued an update to its clinical practice guideline on the use of bone-modifying agents, in particular, osteoclast inhibitors, to prevent and treat skeletal complications from bone metastases in patients with metastatic breast cancer...
More... |
| All times are GMT -7. The time now is 06:54 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021